SCHEMBL24046904

SCHEMBL24046904

C#Cc1cc(-c2cc(=O)c3ccccc3o2)ccc1C(=O)O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TNKS O95271 12/20 0.61
▸ SMN1; SMN2 Q16637 6/20 0.56
▸ PARP1 P09874 5/20 0.56
▸ TNKS2 Q9H2K2 5/20 0.56
▸ HPGD P15428 5/20 0.56
▸ PLA2G2A P14555 4/20 0.56
▸ PLA2G4A P47712 4/20 0.56
▸ CYP3A4 P08684 4/20 0.56
▸ RAB9A P51151 4/20 0.56
▸ NPC1 O15118 3/20 0.56
▸ GABRP O00591 3/20 0.56
▸ GABRD O14764 3/20 0.56
▸ GABRA1 P14867 3/20 0.56
▸ GABRB1 P18505 3/20 0.56
▸ GABRG2 P18507 3/20 0.56
▸ GABRB3 P28472 3/20 0.56
▸ GABRA5 P31644 3/20 0.56
▸ GABRA3 P34903 3/20 0.56
▸ GABRA2 P47869 3/20 0.56
▸ GABRB2 P47870 3/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24046864 0.84 TNKS (0.71) TNKSSMN1; SMN2PARP1TNKS2HPGD
SCHEMBL24046875 0.83 MAOB (0.60) TNKSSMN1; SMN2TNKS2HPGDCYP3A4
SCHEMBL24046906 0.81 TNKS (0.65) TNKSSMN1; SMN2PARP1TNKS2HPGD
SCHEMBL24046902 0.80 TNKS (0.64) TNKSSMN1; SMN2PARP1TNKS2HPGD
SCHEMBL2032421 0.76 TNKS (1.00) TNKSSMN1; SMN2PARP1TNKS2HPGD
SCHEMBL24047003 0.74 ABCB1 (0.61) SMN1; SMN2HPGDCYP3A4RAB9ANPC1
SCHEMBL1095325 0.74 ACMSD (0.58) —
SCHEMBL23070093 0.74 TNKS (0.93) TNKSSMN1; SMN2PARP1TNKS2HPGD
Flavone SCHEMBL15676601 0.73 TNKS (1.00) TNKSSMN1; SMN2PARP1TNKS2HPGD
Flavone SCHEMBL18879 0.73 TNKS (1.00) TNKSSMN1; SMN2PARP1TNKS2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021236578-A1 CHROMEN-4-ONE DERIVATIVES, SUCH AS E.G. FLAVONES, FOR USE AS CK2 INHIBITORS FOR THE TREATMENT OF NEUROINFLAMMATION SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) 2021-11-25 — — WO disclosed
Send feedback